Mount Sinai Hospital
600 University Avenue
Dr. Colgan is a surgical and cyto-pathologist with primary interests
in gynecological pathology and the prevention and detection of
He is head of the sections of Gynecological Pathology and
Cytopathology, Mount Sinai Hospital, and Professor, Laboratory Medicine
and Pathobiology, University of Toronto.
Dr. Colgan graduated with an MD from the University of Toronto and
undertook additional training at the Armed Forces Institute of
Pathology (Washington, DC), McMaster University and Johns Hopkins
Dr. Colgan has recently served as Chair of the Curriculum Committee,
College of American Pathologists and is a past member of the Executive
Board, American Society of Cytopathology, a past Chair of the Canadian
Society of Cytology and a past President, Sociey of Canadian
Dr. Colgan’s studies in gynecologic cytology have focused on the
evaluation of the potential benefits and limitations of new visual
intelligence and molecular technologies. The Toronto endometrial
proteomic initiative used a discovery-based proteomic research program
to identify and validate novel biomarkers of endometrial carcinoma.
These protein biomarkers may lead to new methods of screening,
diagnosis, and monitoring of this disease. Surgical pathologic studies
of prophylactic oophorectomy specimens have lead to novel insights into
the pathogenesis of ovarian carcinoma, and the management of women with
familial ovarian carcinoma.
He consults on a regular basis nationally and internationally in the
area of cancer control, and recently collaborated on new guidelines for
classifying tumours of the female reproductive organs for the World
Health Organization. He also consults for industry, holds two patents
and is a member of the Medical Advisory Board for a biotechnology
He has authored nearly 150 peer-reviewed primary publications.